By passing the Clinical Trial Modernization Act, Congress can remove barriers to clinical trial participation and ensure more cancer patients have access to the latest scientific advancements and cutting-edge treatments.
As the administration releases its proposed budget for Fiscal Year 2027, the American Cancer Society Cancer Action Network (ACS CAN) is calling on Congress to maintain its longstanding bipartisan commitment to robust, increased investments in cancer research and prevention.
The American Cancer Society Cancer Action Network (ACS CAN) announces two new members alongside newly-elected leadership officers to the Board of Directors for 2026.
As new federal data show continued declines in youth tobacco use, the American Cancer Society Cancer Action Network (ACS CAN) is urging the U.S. Food and Drug Administration (FDA) to reject any effort to authorize new flavored tobacco products, including coffee, mint and cinnamon. Flavors have long been used by Big Tobacco to appeal to and addict young people to their deadly products.
The American Cancer Society Cancer Action Network (ACS CAN) released today results from a survey exploring cancer patients and survivors’ attitudes toward vaccines.
Our Impact
We advocate for legislation as a catalyst to fight cancer.
62.3%
of the U.S. population protected from secondhand smoke exposure by local or statewide smoke-free laws.
34%
decline in cancer death rates from 1991-2022
33.5 million
people benefited from expanded access to health insurance
Angel is an outstanding volunteer and leader of ACS CAN in Puerto Rico. He is deeply committed to advocating for health equity, providing crucial representation to the Spanish-speaking community and working to improve conditions for cancer patients through legislative and educational initiatives.